ListedSMEChemicalsAMTECH

Amtech Esters IPO

Amtech Esters IPO is an SME IPO raising ₹18 Cr at ₹71 – ₹75 a share. It listed on 17 Sept 2026 at ₹100, +33.3% against its issue price of ₹75, and trades at ₹80 today (+7.0% since issue). It was subscribed 24× in total.

₹75
Issue price
₹80
Price now
+7.0%
Since issue price
17 Sept 2026
Listed on
24×Subscribed (final) · all exchanges

24.0 times more demand than shares on offer

populated partly populated we hold nothing here — the tab says why

How its cohort has done

185 SME issues listed in 2026 that we can price today. This is the group this issue belongs to.

−2.7%
Median return since issue price
51.9%
Now trading below their issue price

Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →

How the book finished

The category split is the number worth reading, not the total.

QIB15×
Non-institutional24×
Retail29×

Demand is spread fairly evenly across investor categories.

See the full split, sub-category by sub-category →

What we hold for this issue

Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.

Category split — who bidQIB, non-institutional and retail, with sub-splits
How demand built over time23 readings held — our own series
Price-point demand curveLive only — NSE stops serving this once bidding closes
Lead managers and registrarNot published — smaller SME issues often name none
Official documentsNo prospectus or exchange filings are available for this issue
Listing-day priceOpened at ₹100 on debut
Performance since listingComputed from our own daily closes

What happens when

8 SeptPre-apply
9 SeptBidding opens
11 SeptBidding closes
16 SeptAllotment
16 SeptRefunds
17 SeptListing
23 OctMandate ends

Track Amtech Esters Limited

Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.

Open the company page

Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.